BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 9550481)

  • 1. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
    Rider LG; Gurley RC; Pandey JP; Garcia de la Torre I; Kalovidouris AE; O'Hanlon TP; Love LA; Hennekam RC; Baumbach LL; Neville HE; Garcia CA; Klingman J; Gibbs M; Weisman MH; Targoff IN; Miller FW
    Arthritis Rheum; 1998 Apr; 41(4):710-9. PubMed ID: 9550481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.
    Shamim EA; Rider LG; Pandey JP; O'Hanlon TP; Jara LJ; Samayoa EA; Burgos-Vargas R; Vazquez-Mellado J; Alcocer-Varela J; Salazar-Paramo M; Kutzbach AG; Malley JD; Targoff IN; Garcia-De la Torre I; Miller FW
    Arthritis Rheum; 2002 Jul; 46(7):1885-93. PubMed ID: 12124873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci.
    Rider LG; Shamim E; Okada S; Pandey JP; Targoff IN; O'Hanlon TP; Kim HA; Lim YS; Han H; Song YW; Miller FW
    Arthritis Rheum; 1999 Jun; 42(6):1285-90. PubMed ID: 10366124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond.
    Chinoy H; Lamb JA; Ollier WE; Cooper RG
    Curr Opin Rheumatol; 2009 Nov; 21(6):588-93. PubMed ID: 19730377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy.
    Furuya T; Hakoda M; Tsuchiya N; Kotake S; Ichikawa N; Nanke Y; Nakajima A; Takeuchi M; Nishinarita M; Kondo H; Kawasaki A; Kobayashi S; Mimori T; Tokunaga K; Kamatani N
    J Rheumatol; 2004 Sep; 31(9):1768-74. PubMed ID: 15338498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy.
    Chinoy H; Payne D; Poulton KV; Fertig N; Betteridge Z; Gunawardena H; Davidson JE; Oddis CV; McHugh NJ; Wedderburn LR; Ollier WE; Cooper RG;
    Rheumatology (Oxford); 2009 Oct; 48(10):1213-7. PubMed ID: 19690132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
    O'Hanlon TP; Carrick DM; Targoff IN; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Blackshear PJ; Plotz PH; Love LA; Miller FW
    Medicine (Baltimore); 2006 Mar; 85(2):111-127. PubMed ID: 16609350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases.
    Ginn LR; Lin JP; Plotz PH; Bale SJ; Wilder RL; Mbauya A; Miller FW
    Arthritis Rheum; 1998 Mar; 41(3):400-5. PubMed ID: 9506566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies.
    O'Hanlon TP; Rider LG; Mamyrova G; Targoff IN; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Shamim EA; Chanock SJ; Foster CB; Bunch T; Reed AM; Love LA; Miller FW
    Arthritis Rheum; 2006 Nov; 54(11):3670-81. PubMed ID: 17075818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.
    Chinoy H; Salway F; John S; Fertig N; Tait BD; Oddis CV; Ollier WE; Cooper RG;
    Rheumatology (Oxford); 2007 Sep; 46(9):1411-6. PubMed ID: 17586554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenetic studies in families of children with juvenile dermatomyositis.
    Reed AM; Pachman LM; Hayford J; Ober C
    J Rheumatol; 1998 May; 25(5):1000-2. PubMed ID: 9598907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical and immunogenetic features in familial and sporadic rheumatoid arthritis.
    Sanders PA; Grennan DM; Dyer PA; Thomson W; deLange GG
    J Rheumatol; 1987 Aug; 14(4):718-22. PubMed ID: 3499510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
    Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
    Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF).
    Barrera P; Balsa A; Alves H; Westhovens R; Maenaut K; Cornélis F; Fritz P; Bardin T; Ceu Maia M; Lopes-Vaz A; Pascual Salcedo D; de la Concha E; Radstake T; van de Putte LB; Migliorini P; Prudhomme JF; Charron D; Spyropoulou M; Mendes A; Spaepen M; Martinez M; Stavropoulos C;
    J Rheumatol; 2001 May; 28(5):968-74. PubMed ID: 11361224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system.
    Hodak E; Klein T; Gabay B; Ben-Amitai D; Bergman R; Gdalevich M; Feinmesser M; Maron L; David M
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):393-402. PubMed ID: 15761416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians.
    O'Hanlon TP; Carrick DM; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Dreyfuss J; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Plotz PH; Love LA; Miller FW
    Medicine (Baltimore); 2005 Nov; 84(6):338-349. PubMed ID: 16267409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
    Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
    Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
    Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
    J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.